Cytotoxicity of Triptolide and Triptolide loaded polymeric micelles in vitro

Toxicology in Vitro

Volumn 25, Issue 8, 2011, Pages 1557-1567

  Zheng, Shunzhen ^a   Löw, Karin ^b   Wagner, Sylvia ^b   Yang, Xiangliang ^c   Briesen, Hagen von ^b   Zou, Shengquan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FRAUNHOFER INSTITUTE FOR BIOMEDICAL ENGINEERING   (Germany)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cytotoxicity; In vitro; Polymeric micelles; Triptolide

Indexed keywords

CASPASE 3; CASPASE 7; DITERPENOID; LACTATE DEHYDROGENASE; TRIPTOLIDE; TRIPTOLIDE LOADED POLYMERIC MICELLE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HT29; CELL VIABILITY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MEMBRANE DAMAGE;

ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CASPASE 3; CASPASE 7; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; DITERPENES; DRUG CARRIERS; DRUGS, CHINESE HERBAL; EPOXY COMPOUNDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; L-LACTATE DEHYDROGENASE; MICELLES; PHENANTHRENES; POLYESTERS; POLYETHYLENE GLYCOLS;

TRIPTERYGIUM WILFORDII;

EID: 82655162266     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.05.020     Document Type: Article

References (45)

1. Antonoff M.B., Chugh R., Borja-Cacho D., Dudeja V., Clawson K.A., Skube S.J., Sorenson B.S., Saltzman D.A., Vickers S.M., Saluja A.K. Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo. Surgery 2009, 146:282-290.
2. Brinker A.M., Ma J., Lipsky P.E., Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 2007, 68:732-766.
3. Brognard J., Dennis P.A. Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants. Cell. Death. Differ. 2002, 9:893-904.
4. Brown S.D., Nativo P., Smith J.A., Stirling D., Edwards P.R., Venugopal B., Flint D.J., Plumb J.A., Graham D., Wheate N.J. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J. Am. Chem. Soc. 2010, 132:4678-4684.
5. Chang H.Y., Yang X. Proteases for cell suicide: functions and regulation of caspases. Microbiol. Mol. Biol. Rev. 2000, 64:821-846.
6. Díaz T.M., Pértega S., Ortega D., López E., Centeno A., Mañez R., Doménech N. FDA/PI flow cytometry assay of complement-mediated cytotoxicity of antibodies generated during xenotransplantation. Cytometry A. 2004, 62:54-60.
7. Dimanche-Boitrel M.T., Pelletier H., Genne P., Petit J.M., Le Grimellec C., Canal P., Ardiet C., Bastian G., Chauffert B. Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells. Int. J. Cancer. 1992, 50(5):677-682.
8. Dimanche-Boitrel M.T., Micheau O., Hammann A., Haugg M., Eymin B., Chauffert B., Solary E. Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells. Int. J. Cancer 1998, 77(5):796-802.
9. El Hilali N., Rubio N., Blanco J. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase. Clin. Cancer. Res 2005, 11:1253-1258.
10. Friedman M., Levin C.E., Lee S.U., Kim H.J., Lee I.S., Byun J.O., Kozukue N. Tomatine-containing green tomato extracts inhibit growth of human breast, colon, liver, and stomach cancer cells. J. Agric. Food Chem. 2009, 57:5727-5733.
11. Hos D., Bock F., Dietrich T., Onderka J., Kruse F.E., Thierauch K.H., Cursiefen C. Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Invest. Ophthalmol. Vis. Sci. 2008, 49:1836-1842.
12. Kawano K., Watanabe M., Yamamoto T., Yokoyama M., Opanasopit P., Okano T., Maitani Y. Enhanced antitumor effect of camptothecin loaded in longcirculating polymeric micelles. J. Control. Release 2006, 112:329-332.
13. Kedar U., Phutane P., Shidhaye S., Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 2010, (Epub ahead of print).
14. Kiviharju T.M., Lecane P.S., Sellers R.G., Peehl D.M. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin. Cancer. Res. 2002, 8:2666-2674.
15. Krishna G., Liu K., Shigemitsu H., Gao M., Raffin T.A., Rosen G.D. PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis. Am. J. Pathol. 2001, 158:997-1004.
16. Krysko D.V., D'Herde K., Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 2006, 11(10):1709-1726.
17. Kupchan S.M., Court W.A., Dailey RG., Gilmore C.J., Bryan R.F. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J. Am. Chem. Soc. 1972, 94:7194-7195.
18. Lamprecht A., Ubrich N., Yamamoto H., Schäfer U., Takeuchi H., Maincent P., Kawashima Y., Lehr C.M. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 2001, 299:775-781.
19. Landen C.N., Kim T.J., Lin Y.G., Merritt W.M., Kamat A.A., Han L.Y., Spannuth W.A., Nick A.M., Jennnings N.B., Kinch M.S., Tice D., Sood A.K. Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer. Neoplasia 2008, 10(11):1259-1267.
20. Lee H.H., Dadgostar H., Cheng Q., Shu J., Cheng G. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 1999, 96:9136-9141.
21. Lee M., Ahn J.H., Eum K.H. The difference in biological properties between parental and v-Ha-ras transformed NIH3T3 cells. Cancer Res. Treat. 2009, 41:3-9.
22. Liang M., Fu J. Triptolide inhibits interferon-gamma-induced programmed death-1-ligand 1 surface expression in breast cancer cells. Cancer Lett. 2008, 270:337-341.
23. Lin W., Garnett M.C., Schacht E., Davis S.S., Illum L. Preparation and in vitro characterization of HSA-mPEG nanoparticles. Int. J. Pharm. 1999, 189:161-170.
24. Lipsky P.E., Tao X.L. A potential new treatment for rheumatoid arthritis: thunder god vine. Semin. Arthritis. Rheum. 1997, 26:713-723.
25. Lu Y., Wang W.J., Leng J.H., Cheng L.F., Feng L., Yao H.P. Inhibitory effect of triptolide on interleukin-18 and its receptor in rheumatoid arthritis synovial fibroblasts. Inflamm. Res. 2008, 57:260-265.
26. Mc Gee M.M., Greene L.M., Ledwidge S., Campiani G., Nacci V., Lawler M., Williams D.C., Zisterer D.M. Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[{dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5) benzoxazepine (PBOX-6) in leukemia cells occurs via the c-jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL. J. Pharmacol. Exp. Ther. 2004, 310(3):1084-1095.
27. Mei Z., Li X., Wu Q., Hu, Yang X. The research on the anti-inflammatory activity and hepatotoxicity of Triptolide-loaded solid lipid nanoparticles. Pharmacol. Res. 2005, 51(4):345-351.
28. Miret S., De Groene E.M., Klaffke W. Comparison of in vitro assays of cellular toxicity in the human hepatic cell line HepG2. J. Biomol. Screen. 2006, 11:184-193.
29. Nishiyama N., Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 2006, 112:630-648.
30. Ormerod M.G., Sun X.M., Snowden R.T., Davies R., Fearnhead H., Cohen G.M. Increased membrane permeability of apoptotic thymocytes: a flow cytometric study. Cytometry 1993, 14:595-602.
31. Peng A., Gu Y., Lin S.Y. Herbal treatment for renal diseases. Ann. Acad. Med. Singapore 2005, 34:44-51.
32. Saha N.R., Usami T., Suzuki Y. A double staining flow cytometric assay for the detection of steroid induced apoptotic leucocytes in common carp (Cyprinus carpio). Dev. Comp. Immunol. 2003, 27:351-363.
33. Salinas I., Rodríguez A., Meseguer J., Esteban M.A. Adenosine arrests apoptosis in lymphocytes but not in phagocytes from primary leucocyte cultures of the teleost fish, Sparus aurata L. Dev. Comp. Immunol. 2007, 31:1233-1241.
34. Sandström K., Håkansson L., Lukinius A., Venge P. A method to study apoptosis in eosinophils by flow cytometry. J. Immunol. Methods 2000, 240:55-68.
35. Schneider U., Schwenk H., Bornkamm G. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int. J. Cancer 1977, 19(5):621-626.
36. Shu B., Duan W., Yao J., Huang J., Jiang Z., Zhang L. Caspase 3 is involved in the apoptosis induced by triptolide in HK-2 cells. Toxicol. In Vitro 2009, 23:598-602.
37. Singh R., Lillard J.J. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 2009, 86:215-223.
38. Tolleson W.H., Melchior W.B., Morris S.M., McGarrity L.J., Domon O.E., Muskhelishvili L., James S.J., Howard P.C. Apoptotic and anti-apoptotic effects of fumonisin B1 in human keratinocytes, fibroblasts, esophageal epithelial cells and hepatoma cells. Carcinogenesis 1996, 17:239-249.
39. Wang Z., Jin H., Xu R., Mei Q., Fan D. Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression. Exp. Mol. Med. 2009, 41:717-727.
40. Wu S.X., Guo N.R. Clinical observation on effect of triptolide tablet in treating patients with psoriasis vulgaris. Chin. J. Integr. Med. 2005, 11:147-148.
41. Xiong F.L., Chen H.B., Chang X.L., Yang Y.J., Xu H.B., Yang X.L. Research progress of triptolide-loaded nanoparticles delivery systems. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2005, 5:4966-4969.
42. Xu L., Chen H., Xu H., Yang X. Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles. Eur. J. Pharm. Biopharm. 2008, 70:741-748.
43. Yang S., Chen J., Guo Z., Xu X.M., Wang L., Pei X.F., Yang J., Underhill C.B., Zhang L. Triptolide inhibits the growth and metastasis of solid tumors. Mol. Cancer. Ther. 2003, 2:65-72.
44. Yasugi K., Nagasaki Y., Kato M., Kataoka K. Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(d,l-lactide) block copolymers as potential drug carrier. J. Control. Release 1999, 62:89-100.
45. Zheng Q., Gong T., Sun X., Zhang Z.R. Synthesis, characterization and in vitro evaluation of triptolide-lysozyme conjugate for renal targeting delivery of triptolide. Arch. Pharm. Res. 2006, 29:1164-1170.